Avalo Therapeutics AVTX
NASDAQ AVTX
$8.51 +1.35 (+18.78%)
As of: Nov 11, 2026 · 3:59 PM EST

Avalo Therapeutics (AVTX) Divestments (2019 - 2020)

Updated

Avalo Therapeutics (AVTX) reported Divestments of $12.84 million for FY2020, up 224.3% from $3.96 million in FY2019.

Analysis

Avalo Therapeutics (AVTX) Divestments (2019 - 2020) Analysis & Trends

  • According to Business Quant data, Divestments came in at $3.96 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - 42.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Avalo Therapeutics 386.09 Mn -587.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -12.84 Mn
Dec 31, 2019 3.96 Mn
API Access

Avalo Therapeutics Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=AVTX&period=max&api_key=YOUR_API_KEY